Hipolin Intrinsic Value
Hipolin intrinsic value. Hipolin (HIPOLIN) median intrinsic value is ₹26.40 from 7 valuation models (range ₹26–₹80), vs current price ₹88.00 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Hipolin share price today.
HIPOLIN Valuation Methods Summary — DCF, Graham Number & P/E
Hipolin intrinsic value across 7 models vs current price ₹88.00 — upside/downside and value range per method. Read HIPOLIN dividend history for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹26.40 | ₹21.12 - ₹31.68 | -70.0% | EPS: ₹0.08, Sector P/E: 25x |
| Book Value Method | asset | ₹58.33 | ₹52.50 - ₹64.16 | -33.7% | Book Value/Share: ₹23.33, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹80.00 | ₹72.00 - ₹88.00 | -9.1% | Revenue/Share: ₹53.33, P/S: 1.5x |
| Simple DCF (5Y) | dcf | ₹61.89 | ₹49.51 - ₹74.27 | -29.7% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹26.40 | ₹23.76 - ₹29.04 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹26.40 | ₹23.76 - ₹29.04 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| Graham Defensive Method | conservative | ₹26.40 | ₹23.76 - ₹29.04 | -70.0% | EPS: ₹0.08, BVPS: ₹23.33 |
HIPOLIN Intrinsic Value vs Market Price — All Valuation Models
Hipolin fair value range ₹26–₹80 vs current market price ₹88.00 across 7 valuation models. Compare with Hipolin valuation methods to assess whether the stock is under or overvalued.
HIPOLIN Intrinsic Value Analysis — Undervalued or Overvalued?
Hipolin median intrinsic value ₹26.40, current price ₹88.00 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of HIPOLIN?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Hipolin (HIPOLIN) is ₹26.40 (median value). With the current market price of ₹88.00, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹26.40 to ₹80.00, indicating ₹26.40 - ₹80.00.
Is HIPOLIN undervalued or overvalued?
Based on our multi-method analysis, Hipolin (HIPOLIN) appears to be trading above calculated value by approximately 70.0%.
HIPOLIN Financial Health — Key Ratios vs Industry Benchmarks
Hipolin financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.60x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
HIPOLIN Cash Flow Quality — Operating & Free Cash Flow
Hipolin operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |